Premium
Surgical option for nonmelanoma skin cancer
Author(s) -
PichardoVelázquez Patricia,
DomínguezCherit Judith,
VegaMemije Ma. Elisa,
MorenoCoutiño Gabriela,
Proy Héctor
Publication year - 2004
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4632.2004.02091.x
Subject(s) - medicine , basal cell carcinoma , mohs surgery , skin cancer , surgery , lesion , basal cell , surgical resection , surgical excision , closure (psychology) , population , cancer , pathology , environmental health , economics , market economy
Background Basal cell carcinoma (BCC) is one of the most frequent malignancies in the general population. Its best treatment option is the complete excision of the lesion. Mohs’ micrographic surgery has demonstrated to be the surgical method with the highest cure rates, however, it is not available in many countries or institutions. Methods We propose, as a treatment option for high‐risk BCC, surgical resection of the tumor with transoperatory histological examination with the hematoxilin‐eosin technique, delaying closure of the wounds until the margins and surgical bed are tumor‐free. Results We studied 83 patients with BCC; 49 were treated with the transoperatory technique and delay closure. We observed no recurrence in any patient that we followed up and there were no complications resulting from the technique in a 25‐month follow up. Conclusions We recommend this technique for tumors with high‐risk of recurrence if Mohs’ micrographic surgery is not available.